Early clinical data validate rare immune cell for Adicet’s off-the-shelf cancer therapy December 6, 2021 Auto Bot BioPharma, biopharma nl, Boston, cancer, cancer immunotherapy, cell therapy, Clinical Trials, non-Hodgkin lymphoma, Pharma 0 Adicet Bio makes its therapies from gamma delta T cells, a rare type of immune cell that the company believes offer advantages compared to other cell therapies. The company now has early Phase 1 data that bring some validation to the approach.